Key Statistics for RTIX
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M USD)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RTIX
- Net Income (M/USD)
RTI Biologics, Inc. processes human and animal musculoskeletal tissues in producing allograft and xenograft implants. The Company's products are used by surgeons to repair bone and other tissue defects, such as vertebrae repair, musculoskeletal reconstruction, fracture repair, joint repair and reconstruction for sports medicine injuries.
More Company Profile & Key Executives for RTIX
|Dean Howard BergyChairman||Brian K HutchisonPresident/CEO|
|Robert P JordheimExec VP/CFO||Thomas F RoseExec VP/Chief Ops Ofcr/Secy|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries